V3 MOMMO
Alternative Names: V3-MOMMOLatest Information Update: 19 Mar 2021
Price :
$50 *
At a glance
- Originator Immunitor
- Class Cancer vaccines; Immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Breast cancer
Most Recent Events
- 19 Mar 2021 Phase II development is ongoing for Breast cancer in Mongolia (PO)
- 01 Jul 2018 Phase-II clinical trials in Breast cancer in Mongolia (PO) (NCT03572361)